Zentera Therapeutics
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $95M
Investors
- 11
About Zentera Therapeutics
Zentera Therapeutics, Inc.Founded in 2020 and headquartered in New York, US, Zentera Therapeutics, Inc. specializes in cancer therapeutics.Zentera Therapeutics focuses on developing small molecule therapeutics aimed at treating cancer. Their lead product, Azenosertib, is designed to specifically address various cancer indications by altering cancer cell functions.Zentera Therapeutics generates revenue through pharmaceutical partnerships and collaborations, especially from the commercialization of Azenosertib.
Who invested in Zentera Therapeutics
11 investors across 2 rounds
See all investors in Zentera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zentera Therapeutics
Who invested in Zentera Therapeutics?
Zentera Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zentera Therapeutics raised?
Zentera Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Zentera Therapeutics last raise money?
Zentera Therapeutics's most recent round on record is a Series B, in Aug 2021.
What does Zentera Therapeutics do?
Zentera Therapeutics is a pharmaceuticals company.
Where is Zentera Therapeutics headquartered?
Zentera Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Zentera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Zentera Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Zentera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.